Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy A retrospective competing-risk analysis from the K-CaP registry

Yoon Soo Hah, Kwang Suk Lee, In Young Choi, Ji Youl Lee, Jun Hyuk Hong, Choung Soo Kim, Hyun Moo Lee, Sung Kyu Hong, Seok Soo Byun, Seung Hwan Lee, Koon Ho Rha, Byung Ha Chung, Kyo Chul Koo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A multicenter Korean Prostate Cancer Database (K-CaP) has been established to provide information regarding Korean patients with prostate cancer (PCa). We used the K-CaP registry to investigate the value of age and comorbidity for predicting cancer-specific mortality (CSM) and other-cause mortality (OCM) according to risk grouping. The K-CaP registry includes 2253 patients who underwent radical prostatectomy (RP) between May 2001 and April 2013 at 5 institutions. Preoperative clinicopathologic data were collected and stratified according to the National Comprehensive Cancer Network risk criteria. Survival was evaluated using Gray’s modified log-rank test according to risk category, age (<70 years vs ≥70 years), and Charlson comorbidity index (CCI) (0 vs ≥1). The median follow-up was 55.0 months (interquartile range: 42.0–70.0 months). Competing-risk regression analysis revealed that, independent of CCI, ≥70-year-old high-risk patients had significantly greater CSM than <70-year-old high-risk patients (P = .019). However, <70-year-old high-risk patients with a CCI of ≥1 had similar CSM relative to ≥70-year-old patients. Survival was not affected by age or CCI among low-risk or intermediate-risk patients. Multivariate analysis revealed that a CCI of ≥1 was independently associated with a higher risk of CSM (P = .003), while an age of ≥70 years was independently associated with a higher risk of OCM (P = .005). Age and comorbidity were associated with survival after RP among patients with high-risk PCa, although these associations were not observed among low-risk or intermediate-risk patients. Therefore, older patients with high-risk diseases and greater comorbidity may require alternative multidisciplinary treatment.

Original languageEnglish
Article numbere12766
JournalMedicine (United States)
Volume97
Issue number42
DOIs
Publication statusPublished - 2018 Oct 1

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy A retrospective competing-risk analysis from the K-CaP registry'. Together they form a unique fingerprint.

  • Cite this